- Easy Tracking In The Watchlist
Evaluation of Tekla Life Sciences Investors stock downgraded after the last trading session
(Updated on Jun 22, 2026)
The Tekla Life Sciences Investors stock price gained 2.12% on the last trading day (Monday, 22nd Jun 2026), rising from $17.96 to $18.34. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 1.63% from a day low at $18.15 to a day high of $18.45. The price has risen in 7 of the last 10 days and is up by 8.39% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 43 thousand more shares were traded than the day before. In total, 164 thousand shares were bought and sold for approximately $3.01 million.
The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $18.53 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 3.49% during the next 3 months and, with a 90% probability hold a price between $17.16 and $19.18 at the end of this 3-month period.
HQL Signals & Forecast
The Tekla Life Sciences Investors stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $17.47 and $17.53. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 11.08%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Tekla Life Sciences Investors stock
Tekla Life Sciences Investors finds support from accumulated volume at $17.96 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.295 (1.63%) between high and low. For the last week, the stock has had daily average volatility of 1.56%.
Our recommended stop-loss: $17.64 (-3.80%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 7 days ago.)
Trading Expectations (HQL) For The Upcoming Trading Day Of Tuesday 23rd
For the upcoming trading day on Tuesday, 23rd we expect Tekla Life Sciences Investors to open at $18.31, and during the day (based on 14 day Average True Range), to move between $18.14 and $18.54, which gives a possible trading interval of +/-$0.400 (+/-2.21%) up or down from last closing price. If Tekla Life Sciences Investors takes out the full calculated possible swing range there will be an estimated 2.21% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $17.96, some $0.380 (2.07%) from the current price of $18.34, our system finds the risk reward attractive.
Is Tekla Life Sciences Investors stock A Buy?
Tekla Life Sciences Investors holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.
Current score:
0.000
Hold/Accumulate
Downgraded
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on June 23, 2026 - $18.31 ( 0.154%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
HQL Performance
Trading levels for HQL
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 18.61 | 1.45% |
| R2 | 18.49 | 0.84% |
| R1 | 18.42 | 0.460% |
| Price | 18.34 | |
| S1 | 18.20 | -0.769% |
| S2 | 18.13 | -1.15% |
| S3 | 18.02 | -1.76% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 18.34 | |
| S1 | 17.96 | -2.07% |
| S2 | 17.67 | -3.65% |
| S3 | 16.27 | -11.29% |
HQL Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | May 11, 2026 | May 21, 2026 | Jun 30, 2026 | $0.560 | 3.08% |
| 2 | Feb 20, 2026 | Feb 20, 2026 | Mar 31, 2026 | $0.560 | 3.34% |
| 3 | Nov 21, 2025 | Nov 21, 2025 | Jan 12, 2026 | $0.500 | 2.90% |
| 4 | Aug 22, 2025 | Aug 22, 2025 | Sep 30, 2025 | $0.420 | 3.03% |
| 5 | May 22, 2025 | May 22, 2025 | Jun 30, 2025 | $0.430 | 3.38% |
FAQ
Click here for our free guide on how to buy Tekla Life Sciences Investors Stock.
Buy HQL